The Antiglaucoma Drug Market growth is being propelled by increasing disease prevalence, technological innovation, and rising demand for advanced therapeutic options. Market Overview Growth is supported by wider adoption of prostaglandin analogs, beta-blockers, carbonic anhydrase inhibitors, and fixed-dose combinations. Pharmaceutical companies are focusing on improving drug safety, formulation...